2d
The Hartford Insurance Group: An Insurer I Remain Bullish On, As Its Business Insurance Niche Grows
The Hartford Insurance Group shows business growth, improving fund inflows, strong dividends, and solid credit growth. Check ...
The premium on the database software maker’s 5.2% notes maturing in 2035 widened 0.17 percentage point Friday to 1.71 ...
FS Specialty Lending Fund offers a compelling opportunity as a newly listed, diversified credit CEF trading at a -26.9% ...
As of Friday, December 12, American Bitcoin Corp.’s ABTC share price has surged by 6.01%, which has investors questioning if this is right time to sell.
Appdome today announced at Black Hat Europe the release of the industry's first Agentic AI SecOps Agent designed to autonomously monitor, evaluate, reason, and report on mobile threats and interact ...
MedPage Today on MSN
Trial Results Could Shuffle Order of BTK Inhibitors for CLL/SLL
ORLANDO -- In a phase III trial with potential practice-changing implications, the non-covalent Bruton's tyrosine kinase (BTK ...
Researchers sought to determine whether zanubrutinib plus obinutuzumab would be effective in treating patients with R/R FL.
Researchers sought to determine whether zanubrutinib plus obinutuzumab would be effective in treating patients with R/R FL.
Crypto-backed loans keep rising as Bitcoin dips, driven by long-term holders, cheaper DeFi rates, and platforms like Arch ...
Park City School District told the father his allegations were “unsubstantiated” but wouldn’t release any more information, ...
There were no fatal treatment-emergent adverse events (TEAEs) in either patient group, but exposure-adjusted incidence rates ...
Sacituzumab govitecan and pembrolizumab showed a manageable safety profile in PD-L1–positive metastatic TNBC, with lower dose reduction or discontinuation rates than chemotherapy. The combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback